External validation of the Melanoma Institute Australia Sentinel Node Metastasis Risk Prediction Tool using the National Cancer Database
Author:
Publisher
Elsevier BV
Subject
Dermatology
Reference17 articles.
1. Cancer facts and figures 2022,2022
2. Final trial report of sentinel-node biopsy versus nodal observation in melanoma;Morton;N Engl J Med,2014
3. How should we view the results of the Multicenter Selective Lymphadenectomy Trial-1 (MSLT-1)?;Ross;Ann Surg Oncol,2008
4. Longer follow-up confirms recurrence-free survival benefit of adjuvant pembrolizumab in high-risk stage III melanoma: updated results from the EORTC 1325-MG/KEYNOTE-054 trial;Eggermont;J Clin Oncol,2020
5. Complications associated with sentinel lymph node biopsy for melanoma;Wrightson;Ann Surg Oncol,2003
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database;Journal of the American Academy of Dermatology;2024-09
2. Response to Prieto et al, “RE: External validation of the Melanoma Institute Australia sentinel lymph metastasis risk prediction tool using the National Cancer Database”;Journal of the American Academy of Dermatology;2024-09
3. Validation of the Melanoma Institute of Australia’s Sentinel Lymph Node Biopsy Risk Prediction Tool for Cutaneous Melanoma;Annals of Surgical Oncology;2024-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3